Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bioventus Inc. Director's Dealing 2021

Feb 12, 2021

32934_dirs_2021-02-11_81bd6d0f-4b18-4064-8f18-15f9c4b093bd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: Spindletop Healthcare Capital, L.P. (10% Owner)
Reporting Person: Spindletop Capital GP, L.P. (10% Owner)
Reporting Person: Spindletop GP Management, LLC (10% Owner)
Reporting Person: Melrose Evan S (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 3906395 Indirect

Footnotes

F1: The Class A Common Stock reported herein are held of record by Spindletop Healthcare Capital L.P. ("Spindletop"). Spindletop GP Management, LLC ("Spindletop GP") is the general partner of Spindletop Capital GP, L.P., which is the general partner of Spindletop. Mr. Melrose is the manager of Spindletop GP and may deemed to beneficially own the shares of Class A Common Stock held of record by Spindletop. Mr. Melrose disclaims ownership of such securities except to the extent of his pecuniary interest therein.